|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.84 USD | -0.45% |
|
-1.99% | +7.07% |
| Oct. 27 | Universal Health Realty Income Trust reports financial results for the three and nine-month periods ended September 30, 2025 | RE |
| Oct. 27 | Universal Health Realty posts stable Q3 net income | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.52 | 3.51 | 3.3 | 3.38 | 4.04 | |||||
Return on Total Capital | 3.72 | 3.69 | 3.44 | 3.52 | 4.21 | |||||
Return On Equity % | 11.41 | 55.37 | 9.09 | 7.16 | 10.11 | |||||
Return on Common Equity | 11.41 | 55.37 | 9.09 | 7.16 | 10.11 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 94.81 | 94.88 | 94.45 | 94.5 | 94.53 | |||||
SG&A Margin | - | - | - | - | - | |||||
EBITDA Margin % | 66.62 | 67.4 | 63.46 | 62.15 | 65.13 | |||||
EBITA Margin % | 38.42 | 38.71 | 37.1 | 35.71 | 39.6 | |||||
EBIT Margin % | 34.76 | 35.66 | 34.7 | 33.64 | 37.96 | |||||
Income From Continuing Operations Margin % | 24.4 | 126.96 | 22.98 | 15.91 | 19.18 | |||||
Net Income Margin % | 24.4 | 126.96 | 22.98 | 15.91 | 19.18 | |||||
Net Avail. For Common Margin % | 24.4 | 126.96 | 22.98 | 15.91 | 19.18 | |||||
Normalized Net Income Margin | 15.25 | 15.88 | 14.36 | 10.09 | 11.99 | |||||
Levered Free Cash Flow Margin | 51.5 | -54.9 | 42.11 | 40.71 | 37.6 | |||||
Unlevered Free Cash Flow Margin | 57.02 | -49.42 | 48.66 | 50.89 | 48.58 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.16 | 0.16 | 0.15 | 0.16 | 0.17 | |||||
Fixed Assets Turnover | 0.18 | 0.19 | 0.2 | 0.21 | 0.22 | |||||
Receivables Turnover (Average Receivables) | 7.15 | 1.57 | 0.86 | 0.9 | 0.93 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.93 | 10.29 | 9.63 | 8.73 | 10.68 | |||||
Quick Ratio | 0.93 | 10.29 | 9.63 | 8.73 | 10.68 | |||||
Operating Cash Flow to Current Liabilities | 2.51 | 4.21 | 3.85 | 3.31 | 4.5 | |||||
Days Sales Outstanding (Average Receivables) | 51.21 | 232.82 | 426.7 | 406.3 | 391.97 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 193.58 | 144.59 | 154.64 | 184.34 | 211.19 | |||||
Total Debt / Total Capital | 65.94 | 59.12 | 60.73 | 64.83 | 67.86 | |||||
LT Debt/Equity | 190.89 | 144.33 | 154.37 | 183.99 | 210.59 | |||||
Long-Term Debt / Total Capital | 65.02 | 59.01 | 60.62 | 64.71 | 67.67 | |||||
Total Liabilities / Total Assets | 67.81 | 60.68 | 62.29 | 66.31 | 69.09 | |||||
EBIT / Interest Expense | 3.35 | 3.48 | 2.96 | 1.92 | 2.02 | |||||
EBITDA / Interest Expense | 6.48 | 6.64 | 5.47 | 3.59 | 3.5 | |||||
(EBITDA - Capex) / Interest Expense | 6.48 | 6.64 | 5.47 | 3.59 | 3.5 | |||||
Total Debt / EBITDA | 5.74 | 5.82 | 6.02 | 6.09 | 5.74 | |||||
Net Debt / EBITDA | 5.64 | 5.44 | 5.68 | 5.84 | 5.54 | |||||
Total Debt / (EBITDA - Capex) | 5.74 | 5.82 | 6.02 | 6.09 | 5.74 | |||||
Net Debt / (EBITDA - Capex) | 5.64 | 5.44 | 5.68 | 5.84 | 5.54 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 0.96 | 7.87 | 6.78 | 5.41 | 3.62 | |||||
Gross Profit, 1 Yr. Growth % | 0.79 | 7.95 | 6.3 | 5.47 | 3.66 | |||||
EBITDA, 1 Yr. Growth % | -0.21 | 9.13 | 0.54 | 3.22 | 8.6 | |||||
EBITA, 1 Yr. Growth % | -0.68 | 8.68 | 2.34 | 1.46 | 14.92 | |||||
EBIT, 1 Yr. Growth % | 0.6 | 10.65 | 3.9 | 2.19 | 16.95 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 2.55 | 461.35 | -80.67 | -27.02 | 24.9 | |||||
Net Income, 1 Yr. Growth % | 2.55 | 461.35 | -80.67 | -27.02 | 24.9 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 2.17 | 461.7 | -80.68 | -27.45 | 25.23 | |||||
Normalized Net Income, 1 Yr. Growth % | 14.31 | 12.37 | -3.43 | -25.92 | 23.04 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.55 | -0.68 | 2.45 | -1.28 | -3.93 | |||||
Accounts Receivable, 1 Yr. Growth % | 0.94 | 780.02 | 3.45 | 0.19 | 0.29 | |||||
Total Assets, 1 Yr. Growth % | 1.07 | 21.14 | 1.52 | -1.84 | -2.6 | |||||
Common Equity, 1 Yr. Growth % | -12.51 | 48 | -2.65 | -12.29 | -10.65 | |||||
Tangible Book Value, 1 Yr. Growth % | -11.91 | 53.03 | -2.53 | -12.67 | -10.22 | |||||
Cash From Operations, 1 Yr. Growth % | 3.65 | 7.95 | -1.93 | -8.26 | 9.25 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 6.09 | -205.26 | -181.91 | 1.9 | -4.29 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.82 | -186.28 | -205.13 | 10.24 | -1.08 | |||||
Dividend Per Share, 1 Yr. Growth % | 1.47 | 1.45 | 1.43 | 1.41 | 1.39 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.11 | 4.35 | 7.32 | 6.09 | 4.51 | |||||
Gross Profit, 2 Yr. CAGR % | 0.94 | 4.3 | 7.12 | 5.88 | 4.56 | |||||
EBITDA, 2 Yr. CAGR % | -0.13 | 4.36 | 4.75 | 1.87 | 5.88 | |||||
EBITA, 2 Yr. CAGR % | -2.53 | 3.89 | 5.46 | 1.9 | 7.98 | |||||
EBIT, 2 Yr. CAGR % | -1.35 | 5.5 | 7.22 | 3.04 | 9.32 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -10.35 | 139.93 | 4.17 | -62.44 | -4.53 | |||||
Net Income, 2 Yr. CAGR % | -10.35 | 139.93 | 4.17 | -62.44 | -4.53 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -10.49 | 139.56 | 4.17 | -62.56 | -4.68 | |||||
Normalized Net Income, 2 Yr. CAGR % | 2.53 | 13.33 | 4.17 | -15.42 | -4.53 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.7 | 0.92 | 0.87 | 0.57 | -2.62 | |||||
Accounts Receivable, 2 Yr. CAGR % | 2.4 | 198.05 | 201.72 | 1.81 | 0.24 | |||||
Total Assets, 2 Yr. CAGR % | 1.05 | 10.65 | 10.9 | -0.17 | -2.22 | |||||
Common Equity, 2 Yr. CAGR % | -10.52 | 13.79 | 20.04 | -7.6 | -11.47 | |||||
Tangible Book Value, 2 Yr. CAGR % | -9.85 | 16.1 | 22.13 | -7.74 | -11.45 | |||||
Cash From Operations, 2 Yr. CAGR % | 1.48 | 5.78 | 2.89 | -5.15 | 0.11 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 7.44 | 10.45 | -7.15 | -8.64 | -1.24 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 5.1 | -2.43 | -4.76 | 7.66 | 4.43 | |||||
Dividend Per Share, 2 Yr. CAGR % | 1.48 | 1.46 | 1.44 | 1.42 | 1.4 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.16 | 3.31 | 5.16 | 6.68 | 5.26 | |||||
Gross Profit, 3 Yr. CAGR % | 2.06 | 3.22 | 4.97 | 6.57 | 5.14 | |||||
EBITDA, 3 Yr. CAGR % | 1 | 2.87 | 3.07 | 4.24 | 4.07 | |||||
EBITA, 3 Yr. CAGR % | -0.96 | 1.07 | 3.37 | 4.11 | 6.07 | |||||
EBIT, 3 Yr. CAGR % | 1.56 | 2.49 | 4.97 | 5.52 | 7.49 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -24.74 | 65.24 | 3.62 | -7.48 | -43.94 | |||||
Net Income, 3 Yr. CAGR % | -24.74 | 65.24 | 3.62 | -7.48 | -43.94 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -25.04 | 65.1 | 3.5 | -7.66 | -44.01 | |||||
Normalized Net Income, 3 Yr. CAGR % | 5.87 | 5.71 | 7.44 | -7.02 | -4.16 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.47 | 0.9 | 1.43 | 0.15 | -0.96 | |||||
Accounts Receivable, 3 Yr. CAGR % | 5.55 | 109.74 | 109.46 | 108.94 | 1.3 | |||||
Total Assets, 3 Yr. CAGR % | 0.27 | 7.35 | 7.52 | 6.48 | -0.99 | |||||
Common Equity, 3 Yr. CAGR % | -8.94 | 5.82 | 8.03 | 8.11 | -8.62 | |||||
Tangible Book Value, 3 Yr. CAGR % | -8.14 | 7.54 | 9.53 | 9.21 | -8.57 | |||||
Cash From Operations, 3 Yr. CAGR % | -1.32 | 3.59 | 3.15 | -0.97 | -0.57 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 5.82 | 9.9 | -0.03 | -4.23 | -7.21 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 3.55 | 1.08 | 0.02 | -0 | 4.66 | |||||
Dividend Per Share, 3 Yr. CAGR % | 1.49 | 1.47 | 1.45 | 1.43 | 1.41 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.7 | 3.75 | 4.19 | 4.41 | 4.9 | |||||
Gross Profit, 5 Yr. CAGR % | 3.56 | 3.79 | 4.06 | 4.28 | 4.8 | |||||
EBITDA, 5 Yr. CAGR % | 3.2 | 3.17 | 2.48 | 2.47 | 4.18 | |||||
EBITA, 5 Yr. CAGR % | 1.33 | 0.94 | 1.56 | 1.4 | 5.19 | |||||
EBIT, 5 Yr. CAGR % | 3.64 | 2.91 | 3.79 | 2.71 | 6.69 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -3.87 | 44.69 | -14.29 | -8.64 | 0.28 | |||||
Net Income, 5 Yr. CAGR % | -3.87 | 44.69 | -14.29 | -8.64 | 0.28 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -4.55 | 44.01 | -14.5 | -8.81 | 0.14 | |||||
Normalized Net Income, 5 Yr. CAGR % | 5.4 | 4.89 | 5.18 | -3.31 | 2.48 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3 | 0.11 | 0.63 | 0.77 | -0.21 | |||||
Accounts Receivable, 5 Yr. CAGR % | 10.8 | 65.39 | 60.66 | 57.08 | 55.98 | |||||
Total Assets, 5 Yr. CAGR % | 1.5 | 2.66 | 4.39 | 4.27 | 3.51 | |||||
Common Equity, 5 Yr. CAGR % | -4 | 4.23 | 1.7 | 0.23 | -0.24 | |||||
Tangible Book Value, 5 Yr. CAGR % | -3.42 | 6.12 | 2.94 | 1.15 | 0.6 | |||||
Cash From Operations, 5 Yr. CAGR % | 2.98 | 3.22 | 0.35 | 0.01 | 1.92 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 5.57 | 4.76 | 2.22 | 2.07 | -0.51 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 4.52 | -0.36 | 1.77 | 3.66 | 1.76 | |||||
Dividend Per Share, 5 Yr. CAGR % | 1.52 | 1.49 | 1.47 | 1.45 | 1.43 |
Select your edition
All financial news and data tailored to specific country editions
















